[DPHARMA] QoQ Cumulative Quarter Result on 30-Jun-2021 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- 87.37%
YoY- 16.66%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 185,941 639,175 493,731 321,893 166,454 569,902 435,816 -43.35%
PBT 26,646 82,983 65,856 43,373 23,176 76,157 55,686 -38.85%
Tax -6,355 -17,300 -15,889 -10,369 -5,562 -17,547 -13,269 -38.81%
NP 20,291 65,683 49,967 33,004 17,614 58,610 42,417 -38.86%
-
NP to SH 20,291 65,683 49,967 33,004 17,614 58,610 42,417 -38.86%
-
Tax Rate 23.85% 20.85% 24.13% 23.91% 24.00% 23.04% 23.83% -
Total Cost 165,650 573,492 443,764 288,889 148,840 511,292 393,399 -43.85%
-
Net Worth 621,987 621,564 612,147 614,350 635,424 642,484 584,565 4.22%
Dividend
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Div - 21,660 4,708 3,530 - 45,891 3,479 -
Div Payout % - 32.98% 9.42% 10.70% - 78.30% 8.20% -
Equity
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Net Worth 621,987 621,564 612,147 614,350 635,424 642,484 584,565 4.22%
NOSH 941,765 941,765 941,765 706,330 706,026 706,026 706,026 21.19%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 10.91% 10.28% 10.12% 10.25% 10.58% 10.28% 9.73% -
ROE 3.26% 10.57% 8.16% 5.37% 2.77% 9.12% 7.26% -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 20.03 67.87 52.43 45.58 23.58 80.72 62.63 -53.26%
EPS 2.19 6.98 5.31 4.67 2.49 8.46 6.16 -49.84%
DPS 0.00 2.30 0.50 0.50 0.00 6.50 0.50 -
NAPS 0.67 0.66 0.65 0.87 0.90 0.91 0.84 -14.00%
Adjusted Per Share Value based on latest NOSH - 706,330
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 19.32 66.40 51.29 33.44 17.29 59.20 45.27 -43.34%
EPS 2.11 6.82 5.19 3.43 1.83 6.09 4.41 -38.85%
DPS 0.00 2.25 0.49 0.37 0.00 4.77 0.36 -
NAPS 0.6461 0.6457 0.6359 0.6382 0.6601 0.6674 0.6072 4.23%
Price Multiplier on Financial Quarter End Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 -
Price 1.49 1.68 1.81 3.03 2.75 3.38 3.16 -
P/RPS 7.44 2.48 3.45 6.65 11.66 4.19 5.05 29.50%
P/EPS 68.17 24.09 34.11 64.83 110.23 40.72 51.84 20.04%
EY 1.47 4.15 2.93 1.54 0.91 2.46 1.93 -16.61%
DY 0.00 1.37 0.28 0.17 0.00 1.92 0.16 -
P/NAPS 2.22 2.55 2.78 3.48 3.06 3.71 3.76 -29.64%
Price Multiplier on Announcement Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 17/05/22 15/02/22 18/11/21 17/08/21 03/05/21 22/02/21 12/11/20 -
Price 1.51 1.60 1.62 2.49 2.93 3.42 4.04 -
P/RPS 7.54 2.36 3.09 5.46 12.43 4.24 6.45 10.98%
P/EPS 69.08 22.94 30.53 53.28 117.44 41.20 66.28 2.79%
EY 1.45 4.36 3.28 1.88 0.85 2.43 1.51 -2.66%
DY 0.00 1.44 0.31 0.20 0.00 1.90 0.12 -
P/NAPS 2.25 2.42 2.49 2.86 3.26 3.76 4.81 -39.76%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment